ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $113,000 | +52.7% | 2,169 | +38.6% | 0.00% | +33.3% |
| Q2 2022 | $74,000 | +21.3% | 1,565 | +83.7% | 0.00% | +50.0% |
| Q1 2022 | $61,000 | -46.5% | 852 | -44.3% | 0.00% | -50.0% |
| Q4 2021 | $114,000 | +395.7% | 1,529 | +224.6% | 0.00% | +300.0% |
| Q1 2021 | $23,000 | -41.0% | 471 | -44.8% | 0.00% | -75.0% |
| Q3 2020 | $39,000 | -17.0% | 853 | -8.6% | 0.00% | -20.0% |
| Q2 2020 | $47,000 | +261.5% | 933 | +522.0% | 0.01% | +25.0% |
| Q2 2019 | $13,000 | +1200.0% | 150 | +1566.7% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 9 | -55.0% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |